NutriBand price to sales ratio NTRB

Market value divided by revenue over the last twelve months, since 2021.

Today, Oct 23, 2026: 43.3×
5-year median: 22.0×
Against its 5-year history: 95th; percentile: 0 is its lowest day, 100 its highest
5-year range: 7.3× to 61.1×
Peer median: 1.6×

NutriBand's price to sales ratio is 43.3× as of Oct 23, 2026.

That is above its 5-year median of 22.0×, higher than on 95% of days in the last 5 years.

Over that time it ranged from 7.3× in Oct 2023 to 61.1× in Sep 2026.

The median for 9 medical instruments and supplies stocks of a similar size is 1.6×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	43.3×	19.2×	61.1×
2025	25.7×	22.3×	46.9×
2024	21.1×	9.0×	48.7×
2023	8.7×	7.3×	19.0×
2022	13.8×	13.6×	33.8×
2021	52.5×	18.9×	52.5×

Against its peers

Companies in Medical - Instruments & Supplies nearest NutriBand's size, closest first, today.

Company	Price to sales ratio
NTRBNutriBand	43.3×
APTAlpha Pro Tech	0.9×
KEQUKewaunee Scientific	0.3×
NEPHNephros	1.9×
PDEXPro DEX	2.6×
UTMDUtah Medical Products	6.5×
INFUInfuSystem	1.9×
EMBCEmbecta	0.4×
TCMDTactile Systems Technology	1.5×
MDXGMimedx	1.6×
Peer median	1.6×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on NutriBand

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.